Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-25-042533
Filing Date
2025-04-30
Accepted
2025-04-30 16:17:52
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM-10-K/A rnaz-20241231x10ka.htm   iXBRL 10-K/A 544326
2 EXHIBIT-31.2 rnaz-20241231xex31d2.htm EX-31.2 4887
  Complete submission text file 0001104659-25-042533.txt   906363

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20241231.xsd EX-101.SCH 3711
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20241231_lab.xml EX-101.LAB 25531
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20241231_pre.xml EX-101.PRE 17373
20 EXTRACTED XBRL INSTANCE DOCUMENT rnaz-20241231x10ka_htm.xml XML 13969
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40363 | Film No.: 25895642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)